Good point. My guess is that with some googling, the median 23andme customer would find out about SNPedia and find some tool they trust. Of course, requiring even a tiny bit of open-ended research on the part of the prospective consumer is what constitutes the trivial inconvenience.
Re: 23andme supplicating USG, that seems like a reasonable strategy for advancing personal genomics. Across-the-board liberalization of drugs and medical devices won’t happen soon.
Good point. My guess is that with some googling, the median 23andme customer would find out about SNPedia and find some tool they trust. Of course, requiring even a tiny bit of open-ended research on the part of the prospective consumer is what constitutes the trivial inconvenience.
Re: 23andme supplicating USG, that seems like a reasonable strategy for advancing personal genomics. Across-the-board liberalization of drugs and medical devices won’t happen soon.